nogrЭкспериментальная и клиническая гастроэнтерологияExperimental and Clinical Gastroenterology1682-8658«Global Media Technologies»10.31146/1682-8658-ecg-176-4-128-132nogr-1316Research ArticleЭКСПЕРИМЕНТАЛЬНАЯ ГАСТРОЭНТЕРОЛОГИЯEXPERIMENTAL GASTROENTEROLOGYРоль печени в модификации пептидергических механизмов регуляции пищеварительных железThe role of liver in modifi cation of peptidergic mechanisms of regulation of digestive glandsЖураеваМ. А.ZhuraevaM. A.

Candidate of Medical Sciences, Associate Professor of the Department of General Practitioners 1,, Faculty of Medicine, applicant

Republic of Uzbekistan, Andizhan, 170127, Atabekova St., 1

mohigul_azimovna@mail.ruАлейникВ. А.AleinikV. A.

Republic of Uzbekistan, Andizhan, 170127, Atabekova St., 1

БабичС. М.BabichS. M.

Candidate of Medical Sciences, Associate Professor, Head of the Department of Social Hygiene and Health Management

Republic of Uzbekistan, Andizhan, 170127, Atabekova St., 1

ЯкуббековаМ. К.YakubbekovaM. K.

Republic of Uzbekistan, Andizhan, 170127, Atabekova St., 1

ЮсуповаН. А.YusupovaN. A.

соискатель, ассистент кафедры Факультетской терапии

г. Андижан, 170127, ул, Атабекова, 1

Republic of Uzbekistan, Andizhan, 170127, Atabekova St., 1

Андижанский государственный медицинский институтУзбекистанAndijan State Medical InstituteUzbekistan2020250620201744128132Copyright © Жураева М.А., Алейник В.А., Бабич С.М., Якуббекова М.К., Юсупова Н.А., 20202020Жураева М.А., Алейник В.А., Бабич С.М., Якуббекова М.К., Юсупова Н.А.Zhuraeva M.A., Aleinik V.A., Babich S.M., Yakubbekova M.K., Yusupova N.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.nogr.org/jour/article/view/1316печеньутилизацияХЦК-8пентагастринтрипсинконтрикал®крысыжелудочная секрецияподжелудочная секрецияliverutilizationCCK-8pentagastrintrypsincontrycal®ratsgastric secretionpancreas secretionReferencesАлейник В.А., Бабич С. М. Влияние различных доз трипсина на изменение утилизации печенью пентагастрина// Вестник ТМА, 2013, № 1, С. 13–16.Aleynik V. A., Babich S. M. Vliyanie razlichnih doz tripsina na izmenenie utilizatsii pechenju pentagastrina [The effect of various doses of trypsin on the change in liver utilization of pentagastrin]. Vestnik TMA – Bulletin of TMA, 2013, no 1, pp.13–16.Алейник В.А., Бабич С. М. Влияние панкреатических протеолитических и непротеолитических гидролаз на изменение утилизации печенью пентагастрина // Ж-л теор.и клин мед., 2013, № 5, С. 20–23.Aleynik V. A., Babich S. M. Vliyanie pankreaticheskih pro te o liticheskih I neproteoliticheskih gidrolaz na izmenenie utilizatsii pechenj u pentagastrina [The effect of pancreatic proteolytic and non-proteolytic hydrolases on the change in liver utilization of pentagastrin]. Jurnalteoreticheskoy I klinicheskoy medicine – Journal of Theoretical and Clinical Medicine, 2013, no5, pp.20–23.Алейник В.А., Бабич С. М. Изменение панкреатической секреции при введении различных доз трипсина в периферическую и портальную вены// Ж-л теорет.иклин.мед., 2012, № 4, С. 9–12.Aleynik V. A., Babich S. M. Izmenenie pankreaticheskoy sekretsii pri vvedenii razlichnih doz tripsina v perifericheskuju I portalnuju veni [Change in pancreatic secretion with the introduction of various doses of trypsin into the peripheral and portal veins]. Jurnal teoreticheskoy I klinicheskoy medicine – Journal of Theoretical and Clinical Medicine, 2012, no.4, pp.9–12.Бабич С.М., Алейник В. А. Изменение желудочной секреции при введении в периферическую и портальную вены пентагастрина и лей-энкефалина// Ж-л Врач-аспирант, Воронеж, 2010. – № 5,2 (42). – С. 252–257.Babich S. M., Aleynik V. A. Izmenenie jeludochnoy sekretsii priv vedenii v perifericheskuju I portalnuju veni pentagastrina I leyenkefalina [Changes in gastric secretion when pentagastrin and leu-enkephalin are introduced into the peripheral and portal veins]. Journal of vrach-aspirant, Voronej- Journal Postgraduate Student, Voronezh, 2010, no 5,2 (42), pp.252–257Андреева Ю. В. Влияние голодания и возобновления кормления на секреторную функцию желудка/ Дисс., канд. биол. наук, Санкт-Петербург, 2007,140 с.Andreeva Yu. V. Vliyanie golodaniya I vozobnovlenie kormleniya na sekretornuyu funksiyu jeludka. Diss. candidata boil. nauk [The effect of fasting and resumption of feeding on the secretory function of the stomach. Candidate biol. Sci. diss.]. Sankt-Peterburg, 2007, 140 p.Смелышева, Л. Н. Секреторная функция желудка и поджелудочной железы при действии эмоционального стресса / Дисс… канд.мед.наук., Тюмень, 2007, 278 с.Smelisheva L. N. Sekretornaya funksiya jeludka I podjeludochnoy jelezi pri deystvii emotsionalnogo stressa. Diss. candidata med. nauk [Secretory function of the stomach and pancreas under the influence of emotional stress. Candidate med. sci. diss.]. Tyumen, 2007, 278 p.Akere A. et al. Upper gastrointestinal endoscopy in patients with cirrhosis: spectrum and prevalence of lesions. Annals of tropical medicine and public health, 2016, Vol. 9, № 2, P. 112.Akere A. et al. Upper gastrointestinal endoscopy in patients with cirrhosis: spectrum and prevalence of lesions. Annals of tropical medicine and public health, 2016, Vol. 9, № 2, P. 112.Bhattacharyya R. et al. A prospective pilot study of the prevalence of pancreatic disease in patients with alcohol related liver disease using faecal elastase-1. Gut, 2011, Vol.60, Suppl 1, pp. A238-A238.Bhattacharyya R. et al. A prospective pilot study of the prevalence of pancreatic disease in patients with alcohol related liver disease using faecal elastase-1. Gut, 2011, Vol.60, Suppl 1, pp. A238-A238.Hoff master KA, Zamek-Gliszczynski MJ, Pollack GM, Brouwer KL. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport system. J. Pharmacol. Exp. Ther. 2004, vol.311(3), pp.1203–10.Hoff master KA, Zamek-Gliszczynski MJ, Pollack GM, Brouwer KL. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport system. J. Pharmacol. Exp. Ther. 2004, vol.311(3), pp.1203–10.Kalaitzakis E., Bjornsson E. Hepatic encephalopathy in patients with liver cirrhosis: is there a role of malnutrition. World J Gastroenterol, 2008, 14: 3438–3439.Kalaitzakis E., Bjornsson E. Hepatic encephalopathy in patients with liver cirrhosis: is there a role of malnutrition. World J Gastroenterol, 2008, 14: 3438–3439.Katakura Y. et al. Pancreatic involvement in chronic viral hepatitis. World Journal of Gastroenterology: WJG, 2005, Vol.11, № 23, С. 3508.Katakura Y. et al. Pancreatic involvement in chronic viral hepatitis. World Journal of Gastroenterology: WJG, 2005, Vol.11, № 23, С. 3508.Mazaki-Tovi M. et al. Serum gastrin concentrations in dogs with liver disorders. The Veterinary record, 2012, Vol. 171, № 1, pp. 19–19.Mazaki-Tovi M. et al. Serum gastrin concentrations in dogs with liver disorders. The Veterinary record, 2012, Vol. 171, № 1, pp. 19–19.Ramachandran R., Hollenberg M. D. Proteinases and signaling: pathophysiologi-cal and therapeutic implications via PARs and more. Br. J. Pharmacol. 2008. Vol. 153, pp. 263–282.Ramachandran R., Hollenberg M. D. Proteinases and signaling: pathophysiologi-cal and therapeutic implications via PARs and more. Br. J. Pharmacol. 2008. Vol. 153, pp. 263–282.Rehfeld J F., Bundgaard J R., Hannibal J. et al. The Cell-Specific Pattern of Cholecystokinin Peptides in Endocrine Cells Versus Neurons Is Governed by the Expression of Prohormone Convertases 1/3, 2, and 5/6. Endocrinology, 2007, Vol. 149, № 4, pp.1600–1608.Rehfeld J F., Bundgaard J R., Hannibal J. et al. The Cell-Specific Pattern of Cholecystokinin Peptides in Endocrine Cells Versus Neurons Is Governed by the Expression of Prohormone Convertases 1/3, 2, and 5/6. Endocrinology, 2007, Vol. 149, № 4, pp.1600–1608.Valentini L, Schuetz T, Omar A, Gläser S, Kasim E, et al. Abnormal plasma peptide YY(3–36) levels in patients with liver cirrhosis. Nutrition, 2011, 27: 880–884.Valentini L, Schuetz T, Omar A, Gläser S, Kasim E, et al. Abnormal plasma peptide YY(3–36) levels in patients with liver cirrhosis. Nutrition, 2011, 27: 880–884.

The authors declare that there are no conflicts of interest present.